About/Research Funding/Plano/Researching Type 1 Diabetes
Type 1 diabetes (Juvenile Diabetes) is usually diagnosed in children and young adults, and was previously known as juvenile diabetes. Only 5% of people with diabetes have this form of the disease.
In type 1 diabetes, the body does not produce insulin. The body breaks down the sugars and starches you eat into a simple sugar called glucose, which it uses for energy. Insulin is a hormone that the body needs to get glucose from the bloodstream into the cells of the body. With the help of insulin therapy and other treatments, even young children can learn to manage their condition and live long, healthy lives.
18.2 million people in the United States (6.3 percent of the population) have been diagnosed with diabetes. 5 to 10 percent of all people with diabetes have Type 1 Diabetes (T1D). Here is a full list of video credits http://broadcaster.beazil.net/public/credits/youtube/videos/42301 JDRF is the only organization with a strategic research plan to end T1D. Our strategies include: Artificial Pancreas Systems Artificial pancreas systems will eliminate blood glucose testing and carb counting by totally automating insulin dosing, initially preventing dangerous low blood sugars and eventually ensuring ideal glucose control. Complications JDRF’s complications research is leading to therapies to treat and even reverse some of the debilitating, costly, and life-threatening complications caused by T1D. Encapsulation JDRF’s encapsulation research will restore insulin independence for 18 months to two years
by implanting newly created beta cells into a protective capsule, which eliminates the need for toxic immune suppression therapies. The Health Care and Social Assistance industry includes establishments and services such as:
hospitals, nursing and residential care facilities and out-patient care centres; offices of health practitioners (i.e. dentists, doctors, optometrists and chiropractors); medical and diagnostic laboratories; home health care services; ambulance services; social assistance services (i.e. for children, youth, the elderly, families); community food, housing, emergency and relief services; vocational rehabilitation services; and daycare services The historical museum and visitor center is managed by a collaboration between the City of Plano and the Plano Conservancy. The Interurban serves as an archival repository for the Johnnie J. Meyer Collection and Research Center and an educational space for children. Exhibits include a train car that once traveled the tracks through downtown, a permanent exhibit including Plano’s history and an educational piece about electricity. The Plano Conservancy also produces temporary exhibits that change out a couple of times a year. JDRF is the leading global organization funding type 1 diabetes (T1D) research. JDRF’s goal is to progressively remove the impact of T1D from people’s lives until we achieve a world without T1D. JDRF has led the search for a cure for T1D since our founding in 1970. In those days, people commonly called the disease “juvenile diabetes” because it was frequently diagnosed in, and strongly associated with, young children. Our organization began as the Juvenile Diabetes Foundation. Later, to emphasize exactly how we planned to end the disease, we added a word and became the Juvenile Diabetes Research Foundation.Today, we know an equal number of children and adults are diagnosed every day—approximately 110 people per day.
It seems important to mention the main issues –
diabetic ketoacidosis,early detection of diabetes,The Promise Campaign,Hypers,Glucagon,Apidra,Plano,Texas,T1D Staging,diabetes management,Medtronic Minimed Insulin Pump Users,diabetes mellitus,preventive therapy research,fundraising,Research Funding,T1D Care Kit,tolazamide,Living with Type 1,T1D burden,Weight Loss Support,NDEP,T1D Community,Short Acting Insulin,preventive therapies,insulin glulisine,juvenile-onset diabetes,repaglinide,lente insulin,UKPDS Study,young adult diabetes,diabetic retinopathy,diabetic retinopathy,Non-Profit Organization,latent autoimmune diabetes in adults,JDRF One Walk,insulin body site rotation,T1D,insulin lispro,World without T1D,symptoms of T1D,Global Diabetes Research,CGM,charity,blood glucose target range,Political advocacy,Research funding,Premixed insulin,JDRFCC,TrialNet,injection site rotation,Glipizide,Kussmaul breathing,noninsulin-dependent diabetes mellitus,Grassroots model,T1D Team,rebound hyperglycemia,Nutrition,donate today,Diabetes Complications,The Friendship State,ultralente insulin,leading global organization,get support,diabetes diagnosis,LDL cholesterol,Ride to Cure Diabetes,neonatal diabetes,Basal Insulin,implantable insulin pump,Restoration,Estrogen in Type 1 Diabetes,Afrezza,low-density lipoprotein cholesterol,estimated average glucose,glucose,non–insulin-dependent diabetes,Veterans Affairs Diabetes Trial,Standards of Medical Care in Diabetes,renal threshold of.